Hodge C W, Samson H H, Chappelle A M
Department of Physiology and Pharmacology, Wake Forest University, Bowman Gray School of Medicine, Winston-Salem, North Carolina 27157-1083, USA.
Alcohol Clin Exp Res. 1997 Sep;21(6):1083-91. doi: 10.1111/j.1530-0277.1997.tb04257.x.
One of the functions of the mesolimbic dopamine (DA) system is to regulate the process of reinforcement, a process that is thought to influence drug self-administration. This study tested the effects of centrally administered DA receptor ligands on ethanol self-administration behavior. Long-Evans rats were trained to lever press on a fixed-ratio 4 schedule of ethanol (10% v/v) reinforcement. DA agonists and antagonists were then bilaterally microinjected (0.5 microliter/side) into the nucleus accumbens (N Acc) 10-min before sessions to test for effects on the onset, maintenance, and termination of ethanol self-administration. Infusions of the D1-like agonist SKF 38393 (0.03 to 3.0 micrograms) produced no effect on ethanol self-administration. The D1-like antagonist SCH 23390 (0.5 to 2.0 micrograms) reduced total responding by decreasing the time course of self-administration without altering response rate. The D2-like agonist quinpirole produced a biphasic effect on self-administration. Quinpirole (1.0 microgram) increased total responses and response rate, whereas higher doses (4.0 to 10.0 micrograms) decreased total responding as a result of early termination. The D2-like antagonist raclopride (0.1 to 1.0 microgram) reduced total responding by decreasing time course and response rate. Co-administration of either SKF 38393 or SCH 23390 with quinpirole prevented the behavioral effects observed with the low doses of quinpirole. Thus, in the N Acc either increased activation of D1-like receptors or their blockade can affect the expression of the behavioral effects of the D2-like agonist. This suggests that some intermediate level of D1 activation is required to observe the D2 effect. The decreases in total responding produced by raclopride were enhanced by co-administration of SKF 38393, but not altered by SCH 23390, thus suggesting that D1-like and D2-like receptors in the N Acc interact in the regulation of ethanol self-administration in a manner similar to their interactive regulation of other behaviors.
中脑边缘多巴胺(DA)系统的功能之一是调节强化过程,这一过程被认为会影响药物自我给药。本研究测试了中枢给予DA受体配体对乙醇自我给药行为的影响。将Long-Evans大鼠训练为按固定比率4的乙醇(10% v/v)强化程序进行杠杆按压。然后在实验前10分钟,将DA激动剂和拮抗剂双侧微量注射(0.5微升/侧)到伏隔核(N Acc)中,以测试对乙醇自我给药的起始、维持和终止的影响。注射D1样激动剂SKF 38393(0.03至3.0微克)对乙醇自我给药没有影响。D1样拮抗剂SCH 23390(0.5至2.0微克)通过缩短自我给药的时间进程而不改变反应速率,从而降低了总反应。D2样激动剂喹吡罗对自我给药产生双相效应。喹吡罗(1.0微克)增加了总反应和反应速率,而较高剂量(4.0至10.0微克)则由于早期终止而降低了总反应。D2样拮抗剂雷氯必利(0.1至1.0微克)通过缩短时间进程和降低反应速率来降低总反应。将SKF 38393或SCH 23390与喹吡罗共同给药可防止低剂量喹吡罗所观察到的行为效应。因此,在伏隔核中,D1样受体的激活增加或其阻断均可影响D2样激动剂的行为效应的表达。这表明需要一定水平的D1激活才能观察到D2效应。雷氯必利引起的总反应降低通过与SKF 38393共同给药而增强,但不受SCH 23390的影响,因此表明伏隔核中的D1样和D2样受体在乙醇自我给药的调节中相互作用,其方式类似于它们对其他行为的相互调节。